Home / Companies / Frontier Medicines Corporation / Roles
Frontier Medicines Corporation H-1B role rows
Row-level LCA role declarations for Frontier Medicines Corporation, including title, SOC code, worksite, status, date fields, wage offer, prevailing wage, and source record evidence. Showing 9 returned rows using keyset pagination.
Summary
This view lists 9 H-1B LCA role records.
Offered wages among the returned rows range from $105,000 to $210,000.
Employers in the returned rows include Frontier Medicines Corporation.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Role | Employer | SOC | Status / visa | Decision | Worksite | Offered wage | Prevailing wage | Source |
|---|---|---|---|---|---|---|---|---|
| Senior Scientist, Cheminformatics I-200-25055-718572 | Frontier Medicines Corporation | 15-1221.00 Computer and Information Research Scientists | Certified / H-1B FY2025 | 2025-03-03 2025-03-03 to 2028-03-02 | South San Francisco, CA, 94080 | $190,000 to $210,000 year | $179,837 | sr_dol_oflc_lca_2025_q2_row_050762 |
| Lab Manager I-203-23101-921915 | Frontier Medicines Corporation | 17-2031.00 Bioengineers and Biomedical Engineers | Certified - Withdrawn / E-3 Australian FY2025 | 2025-02-10 2023-05-15 to 2025-05-14 | South San Francisco, CA, 94080 | $135,000 to $145,000 year | $118,976 | sr_dol_oflc_lca_2025_q2_row_086504 |
| Senior Scientist, CMC Development I-200-24304-442035 | Frontier Medicines Corporation | 19-1042.00 Medical Scientists, Except Epidemiologists | Certified / H-1B FY2025 | 2024-11-06 2024-12-03 to 2027-12-02 | South San Francisco, CA, 94080 | $165,000 to $185,000 year | $160,826 | sr_dol_oflc_lca_2025_q1_row_061238 |
| Scientist II, Medicinal Chemistry I-200-24095-855417 | Frontier Medicines Corporation | 19-2031.00 Chemists | Certified / H-1B FY2024 | 2024-04-11 2024-10-01 to 2027-09-30 | South San Francisco, CA, 94080 | $150,000 to $160,000 year | $116,813 | sr_dol_oflc_lca_2024_q3_row_196744 |
| Lab Manager I-203-23101-921915 | Frontier Medicines Corporation | 17-2031.00 Bioengineers and Biomedical Engineers | Certified / E-3 Australian FY2023 | 2023-04-18 2023-05-15 to 2025-05-14 | South San Francisco, CA, 94080 | $135,000 to $145,000 year | $118,976 | sr_dol_oflc_lca_2023_q3_row_156089 |
| AI/ML Research Scientist I-200-22133-171222 | Frontier Medicines Corporation | 15-1111.00 Computer and Information Research Scientists | Certified / H-1B FY2022 | 2022-05-20 2022-10-01 to 2025-09-30 | South San Francisco, CA, 94080 | $131,000 to $170,000 year | $130,146 | sr_dol_oflc_lca_2022_q3_row_124875 |
| Artificial Intelligence Scientist I-200-22122-128082 | Frontier Medicines Corporation | 15-1111.00 Computer and Information Research Scientists | Certified / H-1B FY2022 | 2022-05-09 2022-10-01 to 2025-09-30 | South San Francisco, CA, 94080 | $163,342 to $175,000 year | $163,342 | sr_dol_oflc_lca_2022_q3_row_090096 |
| Scientist I, Chemistry I-200-21222-513033 | Frontier Medicines Corporation | 19-2031.00 Chemists | Certified / H-1B FY2021 | 2021-08-16 2021-10-01 to 2024-09-30 | South San Francisco, CA, 94080 | $105,000 year | $100,880 | sr_dol_oflc_lca_2021_q4_row_063167 |
| Scientist I, Chemistry I-200-21217-505030 | Frontier Medicines Corporation | 19-2032.00 Materials Scientists | Withdrawn / H-1B FY2021 | 2021-08-06 2021-10-01 to 2024-09-30 | South San Francisco, CA, 94080 | $105,000 year | $100,194 | sr_dol_oflc_lca_2021_q4_row_049796 |
End of returned pageReset
Frequently asked questions
- What are the offered H-1B wages for Frontier Medicines Corporation H-1B role rows?
- Offered wages among the returned Frontier Medicines Corporation H-1B role rows rows range from $105,000 to $210,000 in DOL LCA filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/roles?limit=50&company=frontier+medicines+corporationJSON